Managed Healthcare Executive September 5, 2025
At the PBMI annual meeting, experts warned that soaring prices for new cancer therapies require greater data sharing, precision medicine and value-based contracts to ensure patients get access to effective treatments without overwhelming costs.
Collaboration, clinical evidence, data sharing and a focus on patient access are some of the critical things needed to provide those with cancer the best care while managing costs, say panelists at a session at the Pharmacy Benefit Management Institute’s annual meeting today in Orlando.
This will be even more critical as new targeted, innovative and costly drugs become available that extend the life of patients with cancer, said Simone Ndujiuba, Pharm.D., BCOP, senior principal clinical oncology pharmacist at Prime Therapeutics, during the panel discussion. “In...
Today's Sponsors
Today's Sponsor